FDA Approves New Oncology Treatments and Multi-Cancer Detection Test

In September 2026, the FDA granted accelerated approvals for several oncology therapies, including treatments for breast cancer and non-small cell lung cancer. Additionally, a multi-cancer early detection test received a positive advisory panel vote, indicating progress in early cancer diagnosis. These developments could enhance treatment options and early detection strategies in oncology.